Article

Working women are “leaning in” and supporting more females in leadership roles, but a new study finds that having a female manager doesn’t necessarily equate to higher salaries for female employees. In fact, women can sometimes take an earnings hit relative to their male colleagues when they go to work for a female manager.

Many of the best, most effective leaders are introverts by nature, schoolyard nerds who grew up to be outstanding at drawing out the best in the people who work for them.

Ursus Remediation Testing & Technologies is an environmental services lab specializing in heavy metal and organic treatability studies, customized testing, and remediation services for engineers, scientists, and regulators to determine the most effective alternatives for achieving the remediation goals of a specific project. Services include sampling design, testing protocols, bench-level treatability testing, field dosage optimization, and in-field remediation implementation.

Michael Rummel has held the position of chief operating officer at InSource Diagnostics, an independent laboratory that focuses on medication monitoring and compliance testing, for several years. Since graduating from the University of Wisconsin-Madison in 2005, Michael has pursued a career working in the analytical and clinical sciences. He has expertise in analytical chemistry assay development specifically with liquid chromatography/mass spectrometry, assay optimization, and sample preparation optimization and development.

Dieter C. Gruenert, PhD, (bottom left) is a professor of otolaryngology—head and neck surgery at the University of California, San Francisco (UCSF) and pediatrics at the University of Vermont (UVM). He has a PhD in biophysics from the University of California at Berkeley and was a postdoctoral fellow in carcinogenesis at L’Institut Suisse de Recherche Expérimentale sur le Cancer in Lausanne. He was co- director of the Gene Therapy Core Center at UCSF, director of the Division of Human Molecular Genetics at UVM, and head of the Stem Cell Research Program at California Pacific Medical Center. His research focuses on development of gene editing and cell-based therapies for inherited diseases and cancer. He has developed novel diagnostic and oligonucleotide-based therapeutic strategies to ameliorate disease pathology.














